Wei Wei

Has grant

Assistant Professor

Institute for Systems Biology

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Wei Wei is an Assistant Professor at the Institute for Systems Biology, located in the United States. His research focuses on cancer systems biology, with recent articles exploring topics such as oncogenic BRAF inhibition and single-cell proteomic studies. He has also contributed to understanding post-acute COVID-19 sequelae and metabolic profiling in cancer cells.

Recent Grants

Grant: Open

Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)

Open Date: 2022-09-22

Close Date: 2027-08-31

Grant: Close

Strategies for discerning chemotherapy response and resistance in ovarian cancer

Open Date: 2022-09-15

Close Date: 2024-08-31

Grant: Close

PRODIGE: A high-throughput tool for joint profiling of protein-DNA interactions and gene expression in single cells

Open Date: 2021-09-30

Close Date: 2023-08-31

Grant: Close

Liquid biopsy-based toolkits for neoantigen and cognate TCR discovery for cancer immunotherapy

Open Date: 2021-09-05

Close Date: 2024-08-31

Grant: Close

Discerning the dysfunctional immune response to SARS-CoV-2 infection in patients with chronic lymphocytic leukemia

Open Date: 2021-05-01

Close Date: 2022-05-01

Articles (12)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (12)

Kristin G Anderson

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Wei Wei

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (12)

Signaling and transcriptional dynamics underlying early adaptation to oncogenic BRAF inhibition

Kinetic Trajectories of Glucose Uptake in Single Cancer Cells Reveal a Drug-Induced Cell-State Change Within Hours of Drug Treatment

Signaling and transcriptional dynamics underlying early adaptation to oncogenic BRAF inhibition

Detection of >400 Cluster of Differentiation Biomarkers and Pathway Proteins in Single Immune Cells by Cyclic Multiplex In Situ Tagging for Single-Cell Proteomic Studies

Non-mass spectrometric targeted single-cell metabolomics

Multiple early factors anticipate post-acute COVID-19 sequelae.

Single-cell profiling of D-2-hydroxyglutarate using surface-immobilized resazurin analogs

Single-Cell Profiling of Fatty Acid Uptake Using Surface-Immobilized Dendrimers

Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients.

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.

Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell line

Cancer Systems Biology in the Era of Single‐Cell Multi‐Omics

Collaborators (12)

Kristin G Anderson

Daniel Chen

Venkata Duvvuri

Jing Li

Min Xue

GUANGRONG QIN

Yue Lu

Jennifer Hadlock

Priyanka Baloni

Michael Zager

Naeha Subramanian

Alissa Rothchild

Make your next move.